FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method of preparing a pharmaceutical composition for use in a method of treating kidney disease in humans. The methods of treating kidney disease by administering an enriched heterogeneous population of kidney cells to a mammalian subject are provided.
EFFECT: use of a selected population of human kidney cells characterized by specific biomarkers and retaining the biomarker expression phenotype in culture after multiple passages allows the use of smaller numbers of cells to provide a regenerative stimulus.
17 cl, 7 dwg, 12 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| KIDNEY CELL POPULATIONS AND USE THEREOF | 2013 |
|
RU2702721C2 |
| ORGANOIDS CONTAINING ISOLATED RENAL CELLS, AND THEIR USE | 2014 |
|
RU2722361C2 |
| IMMUNOLOGICALLY PRIVILEGED BIOACTIVE KIDNEY CELLS FOR TREATMENT OF KIDNEY DISEASE | 2018 |
|
RU2816753C2 |
| COMPOSITIONS CONTAINING CELL VESICLES AND USE THEREOF | 2019 |
|
RU2824136C2 |
| TREATING KIDNEY DISEASE IN SUBJECTS WITH RENAL AND/OR URINARY TRACT ABNORMALITIES | 2020 |
|
RU2823980C2 |
| PREDICTIVE BIOMARKERS AND BIOMARKER SIGNS OF RENAL INTEGRITY TO BE USED IN KIDNEY HEALTH MONITORING | 2008 |
|
RU2519148C2 |
| SC-β CELLS AND COMPOSITIONS AND METHODS FOR THEIR CREATION | 2014 |
|
RU2692595C2 |
| SC-β CELLS AND COMPOSITIONS AND METHODS FOR THEIR CREATION | 2014 |
|
RU2813705C1 |
| SC-β CELLS AND COMPOSITIONS AND METHODS FOR THEIR CREATION | 2014 |
|
RU2772585C2 |
| METHODS AND COMPOSITIONS FOR TREATING CANCER USING ANTISENSE | 2018 |
|
RU2766457C2 |
